Stanford University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Stanford University sits in the top decile of US sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count).

1,744 total trials 264 currently recruiting 1122 completed early-phase tilt top decile by trial count

Stanford University: 1,744 sponsored US clinical trials, 264 recruiting.

Stanford University sponsors 1,744 registered US clinical trials on ClinicalTrials.gov, 264 of them currently recruiting, and 1,122 completed. 137 of these trials are in Phase 3-4 (later-stage) and 402 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 19 trials.

Top-decile sponsor footprint

Stanford University ranks in the top decile of sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,744 total, page 25 of 35

COMPLETED NA

Effects of Oral Probiotic Supplementation on Group B Strep (GBS) Rectovaginal Colonization in Pregnancy

NCT01479478

COMPLETED Phase 1

Omalizumab With Oral Food Immunotherapy With Food Allergies Open Label Safety Study in a Single Center

NCT01510626

COMPLETED

Perfusion CT as a Predictor of Treatment Response in Patients With Rectal Cancer

NCT01460641

COMPLETED Phase 1

Adiponectin Polymorphisms, Insulin Resistance, and Pharmacokinetics in Obesity

NCT01593397

COMPLETED NA

Therapeutic Potential of Myofascial Structural Integration in Children With Cerebral Palsy

NCT01815814

COMPLETED Phase 1

Single Center Food Allergy Oral Immunotherapy Study

NCT01490177

COMPLETED NA

Individualized Lung Tumor Stereotactic Ablative Radiotherapy (iSABR)

NCT01463423

COMPLETED Phase 2

Docetaxel, Cisplatin, and Cetuximab (TPC) in Palliative Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN)

NCT01437449

COMPLETED Phase 2

Pilot Ipilimumab in Stage IV Melanoma Receiving Palliative Radiation Therapy

NCT01449279

COMPLETED

The "Stanford Integrated Psychosocial Assessment for Transplant" (SIPAT)

NCT01633424

COMPLETED NA

DVD-Based Training Program in Self-Hypnosis for Children

NCT01483105

TERMINATED NA

Immunomodulation, IL-1 Inhibition, and Postoperative Incisional Pain

NCT01466764

COMPLETED NA

Prospective Evaluation of Winged Biliary Stent Patency in Patients With Benign Biliary Obstruction

NCT03115411

COMPLETED NA

Treatment of Onychomycosis Using a 0.65 Millisecond Pulsed Nd:YAG 1064 nm Laser

NCT01666002

COMPLETED NA

Adaptive Family Treatment for Adolescent Anorexia Nervosa

NCT01579682

COMPLETED NA

Adipose Tissue Response to Overfeeding in Insulin Resistance-Prone vs. Insulin Sensitive Humans

NCT02084641

COMPLETED

Computed Tomography Perfusion (CTP) to Predict Response to Recanalization in Ischemic Stroke Project (CRISP)

NCT01622517

TERMINATED

Transrectal Photoacoustic Imaging of the Prostate

NCT02365883

COMPLETED Phase 4

Plasmablast Trafficking and Antibody Response in Influenza Vaccination (SLVP021 2011-2014)

NCT02141581

COMPLETED

Thromboelastography in Non-elective Cesarean Delivery

NCT01514591

COMPLETED NA

Feasibility of IMRT Modulation to Account for Scattered Radiation From Dental Fillings in Head and Neck Cancer

NCT01576939

COMPLETED NA

Personal Genomics for Preventive Cardiology

NCT01406808

COMPLETED NA

Influence of Patient Choice of Intrathecal Morphine on Post-cesarean Delivery Pain.

NCT01425762

COMPLETED

Side Effects of Pulmonary Hypertension Medications

NCT01571713

COMPLETED Phase 2

Varenicline In-Patient Study

NCT01413516

COMPLETED

Effects of Breast Feeding on Post-Cesarean and Post-Vaginal Delivery Pain

NCT01417260

COMPLETED NA

Prospective Study to Investigate the Frequency of Possible Bacterial Entry Into the Bloodstream (Bacteremia) and Infectious Complications Associated With the Use of the Spyglass Cholangioscopy System During ERCP (Endoscopic Retrograde Cholangiopancreatography).

NCT01414400

TERMINATED Phase 2

Azacitidine + Lenalidomide Combo in the Elderly With Previously Treated AML & High-Risk MDS

NCT01442714

COMPLETED NA

Triclosan, Triclocarban, and the Microbiota

NCT01509976

COMPLETED

Predictors of Pulmonary Hypertension Risk in Premature Infants With Bronchopulmonary Dysplasia

NCT01516398

COMPLETED Phase 2

A Study of Pregnenolone in the Treatment of Individuals With Autism

NCT01881737

COMPLETED Phase 1

Gait Retraining to Reduce Knee Osteoarthritis Pain

NCT01397981

COMPLETED

Long-term Neurocognitive Sequelae of Subclinical Microembolization During Carotid Interventions

NCT01718600

COMPLETED NA

A Brief Outpatient Problem-solving Intervention to Promote Healthy Eating and Activity Habits in Adolescents

NCT01699958

COMPLETED

SPY Intra-Operative Angiography & Skin Perfusion in Immediate Breast Reconstruction w/ Implants

NCT01315119

COMPLETED NA

Effects of Glutathione (an Antioxidant) and N-Acetylcysteine on Inflammation

NCT01550432

TERMINATED

Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing

NCT01556828

COMPLETED

Ultrarunners Longitudinal TRAcking Study (ULTRA)

NCT02014038

COMPLETED

Diabetic Ketoacidosis and Its Impact on the Brain

NCT01753934

TERMINATED Phase 2

Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma

NCT01313884

TERMINATED Phase 3

Lumbar Transforaminal Epidural Corticosteroid Injection(s) Versus Defined Physical Therapy

NCT01443819

COMPLETED

An Outcomes Study Comparing the Intralase FS 60 to the Intralase iFS When Performing LASIK Surgery for Nearsightedness

NCT01365728

COMPLETED NA

5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Physical Dependence

NCT01549652

COMPLETED NA

Self-Defense Training in Women With Trauma

NCT01380379

COMPLETED NA

Prevention of Postpartum Traumatic Stress (PTSD) in Mothers With Preterm Infants.

NCT01307293

COMPLETED

Ankylosing Spondylitis and Spondyloarthritis Evaluation Tool Study

NCT01302730

COMPLETED

Clinical Performance of the Embrace Isothermal Mattress

NCT01425086

COMPLETED NA

Emotion Regulation During RCT of CBT vs. MBSR for Social Anxiety Disorder

NCT02036658

COMPLETED NA

Practice-Based Learning to Predict Polyp Histology at Colonoscopy

NCT01638091

TERMINATED

High Resolution 3D Diffusion-weighted Breast MRI

NCT01315106

← Previous Page 25 of 35 Next →

Phase Distribution

PhaseTrial count
Phase 1 193
Phase 2 209
Phase 3 51
Phase 4 86

What is open in the Stanford University pipeline

264 recruiting of 1,744 indexed (15% open); 1,122 completed (64%).

Phase mix: 137 late (III/IV) vs 402 early (I/II) (early-phase heavy).

Top condition: Autism Spectrum Disorder (19 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.